Article
Through ‘Radical Transparency,’ Kennedy can Finally Rein in Big Pharma

Article
Fact-based, data-driven research and analysis to advance democratic debate on vital issues shaping people’s lives.
Center for Economic and Policy Research
1611 Connecticut Ave. NW
Suite 400
Washington, DC 20009
Tel: 202-293-5380
Fax: 202-588-1356
https://cepr.net
“The health of America is in jeopardy. Doctors do not have access to the full safety and effectiveness data for the treatments we rely upon. Pharmaceutical companies control and hide information from their clinical trials, preventing health care professionals from making the most informed decisions to best treat patients.
The newly confirmed secretary of the Department of Health and Human Services, Robert F. Kennedy Jr., can take immediate action as part of his prioritization of “radical transparency” to aid his mission to “Make America Healthy Again.”
Read the full piece in The Hill